Pro-BNP Risk Score Calculator
NT-proBNP Clinical Interpretation
Enter the patient’s age and NT-proBNP concentration, then select the clinical setting.
Evidence-based thresholds
Interpretation
Enter patient data
How to interpret NT-proBNP
NT-proBNP is a biomarker used with symptoms, examination, ECG, imaging, and other investigations when heart failure is suspected. It is associated with prognosis in established heart failure, but a concentration alone does not provide an individualized mortality estimate.
Thresholds used by this tool
| Setting | Threshold | Meaning |
|---|---|---|
| Non-acute | <125 pg/mL | Heart failure is less likely; interpret with the clinical assessment. |
| Non-acute, age-adjusted | ≥125 / ≥250 / ≥500 pg/mL | HF is more likely at age <50 / 50–75 / >75 years, respectively; further assessment may be warranted. |
| Acute | <300 pg/mL | Acute heart failure is unlikely, though clinical exceptions occur. |
| Acute, age-specific rule-in | ≥450 / ≥900 / ≥1800 pg/mL | Supports acute HF at age <50 / 50–75 / >75 years, respectively; not diagnostic by itself. |
Important factors affecting results
- Older age, atrial fibrillation, and renal dysfunction can increase NT-proBNP.
- Obesity may result in lower concentrations than expected.
- Other cardiac and non-cardiac conditions can elevate NT-proBNP.
- Use the correct assay and units; BNP and NT-proBNP cutoffs are not interchangeable.
References
McDonagh TA, Metra M, Adamo M, et al.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
2026 ESC Guidelines for the management of heart failure.
European Society of Cardiology / European Heart Journal. 2026. Age-adjusted outpatient NT-proBNP thresholds discussed in the guideline. Official guideline
Heidenreich PA, Bozkurt B, Aguilar D, et al.
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145:e895–e1032. doi:10.1161/CIR.0000000000001063
Clinical disclaimer: This tool provides a threshold-based aid for interpreting NT-proBNP in suspected heart failure. It is not a validated mortality risk score, does not diagnose or exclude heart failure on its own, and must not replace clinical judgement or urgent assessment when indicated. Interpret results in the context of symptoms, examination, renal function, rhythm, body habitus, and other investigations.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.